Hypertensive cerebral hemorrhage, commonly known as cerebral hemorrhage, is a frequent and common disease in internal medicine with acute onset, high disability rate, high mortality rate and slow recovery. Traditional medical treatment is mainly to lower cranial pressure, control blood pressure and prevent complications, and the treatment measures are relatively passive. Surgical procedures, on the other hand, are highly traumatic and costly. Most patients’ conditions and economic situations do not tolerate them, and complications such as rebleeding, massive cerebral infarction, intracranial pneumonia and intracranial infection occur after surgery. Minimally invasive technology provides scientific three-dimensional localization of intracranial hematoma of cerebral hemorrhage, which can remove the hematoma accurately, timely and thoroughly; local anesthesia is less traumatic and medical costs are low, which enables early intervention of rehabilitation treatment, improves the prognosis of comprehensive treatment of hypertensive cerebral hemorrhage and reduces the death and disability rate of the disease. It is a minimally invasive treatment technique with accurate positioning, scientific safety, easy operation, no craniotomy and blood transfusion, and low cost.